1) ¿ª´ë ±³½Ç¿øµéÀÇ Áֿ俬±¸ºÐ¾ß
±³½Ç¿ø
|
Áֿ俬±¸ºÐ¾ß
|
±³½Ç¿ø
|
Áֿ俬±¸ºÐ¾ß
|
Á¶±ÔÂù
|
|
±è¿Á³à
|
¿Ü»ó¾à¸®
|
¾îº´ÀÓ
|
|
±èÀμø
|
ºÐÀھฮ
|
À±±â¿µ
|
|
À̼®¿ë
|
½Å°æ¾à¸®
|
Á¶±Ôö
|
½ÅÀå¾à¸®
|
À̱ÇÇà
|
ºÐÀھฮ
|
ÀÌ»óº¹
|
ÁßÃ߽Űæ¾à¸®, ÀÓ»ó¾à¸®
|
|
|
2) ±³½Ç¿ø ÇØ¿Ü¿¬¼ö
¼º ¸í
|
±â °£
|
±â °ü
|
³ëº´¸²
|
68.3-
|
¹Ì±¹ Å׳׽ôëÇÐ ¾à¸®Çб³½Ç
|
Á¶º´Çå
|
77.8-78
|
ÀϺ» µµ¾ß¸¶ÀÇ´ë ÈÇבּ¸¼Ò
|
ÀÌ»óº¹
|
75.5-
|
Æĸ®ÀÇ°ú´ëÇÐ ¾à¸®Çб³½Ç
|
±è¿Á³à
|
87-89
|
¹Ì±¹ ¸Þ¸±·£µå´ëÇб³ ¾àÇдëÇÐ
|
±èÀμø
|
83.9-90.3
|
¹Ì±¹ºê¶ó¿î´ëÇÐ ¾à¸®Çб³½Ç
|
À̱ÇÇà
|
92.6-94.7
|
¹Ì±¹ NIH
|
À̼®¿ë
|
93.8-95.9
|
¹Ì±¹ ¹Ì³»¼ÒŸ´ëÇÐ ¾à¸®Çб³½Ç
|
±è¼ºÀ±
|
95.3-
|
¹Ì±¹ ·Î¿ç¶ó´ëÇÐ ¾à¸®Çб³½Ç
|
3) ¿¬µµº° ³í¹® ¹ßÇ¥ ÇöȲ
<1961¡1965>
<±¹ ³»>
ÀÌ»óº¹: À°¾ÆÁ¾³¶¹ý(Granuloma pouch technic)À» ÀÌ¿ëÇÑ Steroid ÈÇÕ¹°ÀÇ ¼Ò¿°ÀÛ¿ë ºñ±³. ´ëÇѾฮÇÐȸÀâÁö
1(1): 47-51, 1965.
½ÅÇöö, ³ëºÀÅÃ: ÀûÃâ °³±¸¸® ½ÉÀå¿¡ ´ëÇÑ BradydininÀÇ ÀÛ¿ë. Kor Med J 10(3): 63-66, 1965.
.
<1966¡1970>
<±¹ ³»>
¼°æ¿Á: ´«ºû½Â¸¶ ¾ËÄÝÀ¯Ãâ¹°ÀÇ ÀûÃâÁ¶°³ ½ÉÀå¹Úµ¿¿¡ ´ëÇÑ ÀÛ¿ë. Kor Med J 12(7): 45-50, 1967.
À̱Կë: ¸ÅÀÚ³ª¹«±Ù °áÁ¤(A)ÀÇ ÀûÃâÁ¶°³ ½ÉÀå¹Úµ¿ ¹× °³±¸¸®º¹Á÷±Ù¿¡ ´ëÇÑ ÀÛ¿ë. Kor Med J 13(3): 19-25, 1968.
Á¶¿ëÀÏ, À̱Կë: ¼öÁ¾¾à¹°ÀÌ °³±¸¸®ÀÇ ÀûÇ÷±¸¿¡ ´ëÇÑ ¿µÇâ. Kor Med J 13(3): 27-30, 1968.
À̱Կë, Á¶¿ëÀÏ: ȸ¾ç¸ñ ¾ËÄÝÃßÃâ¹°ÀÇ ¹é¼ÀûÃâÀ۱ÿ¿¡ ´ëÇÑ ÀÛ¿ë. Kor Med J 13(3): 31-34, 1968.
¹ÚÁ¤¼ø, ±èÀ±±Ù: ¿ì¸®³ª¶ó ¹éºÎÀÚ(Aconitum Koreanum R. Raymond)ÀÇ ÀûÃâ °³±¸¸® ½ÉÀå ¿îµ¿¿¡ ´ëÇÑ ÀÛ¿ë
¹× LD50. Kor J Pharmacol 5(2): 1-5, 1969.
¹ÝµÎ°æ, ½Éö, ÀÓ¿ëÈ£: ÀͺÎÃÊ Alcohol ÃßÃâ¹°ÀÇ ÀûÃâ°¡Åä Àå¿îµ¿¿¡ ´ëÇÑ ÀÛ¿ë. Kor Med J 14(1): 37-40,
1969.
ÀüÈñ¼ø, ±èÀ±±Ù, ±è¿Á³à: À¸¾Æ¸®±ÙÀÇ ¾ËÄÝÃßÃâ¹°ÀÇ °³±¸¸® º¹Á÷±Ù¿¡ ´ëÇÑ ÀÛ¿ë. Kor Med J 14(1): 31-36, 1969.
¼Û¼®±Ô: ³ì¿ëÀÌ Åä³¢ÀÇ Á¶Ç÷ÀÎÀÚ ¹× ¹æ»ç¼ºÃ¶ ¼·Ãë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý. 18: 51-60, 1970.
¹ÚÁ¤¼ø: °í·ÁÀλïÀÇ °¢ ºÐ·ù¹°ÀÌ Åä³¢ÀÇ Á¶Ç÷ÀÎÀÚ¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý. 19: 55-68, 1970.
±è¿Á³à: À¸¾Æ¸® »Ñ¸®ÀÇ ¾ËÄÝÃßÃâ¹°ÀÌ ÀûÃâ °¡ÅäÀå°ü¿îµ¿¿¡ ¹ÌÄ¡´Â¿µÇâ. Áß¾ÓÀÇÇÐ 19(4): 293-298, 1970.
<1971¡1975>
<±¹ ³»>
ÀÌ»óº¹, ÀÌ´öÈñ, ÀÌÈï¹ü: ÀλïÀÌ Á¶Ç÷ ±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ. ÃÖ½ÌÀÇÇÐ. 14(3): 91-95, 1971.
ÀÌ»óº¹, Á¶±Ôö: ÀλïÀÌ ½ÇÇèÀû ÄáÆϼº °íÇ÷¾Ð¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý. 20: 89-99, 1971.
ÀÌ»óº¹, ¹ÚÇü°æ: ¹é¼ Ç÷ÀåÁ¶Ç÷ÀÎÀÚ È°¼º¿¡ ¹ÌÄ¡´Â hypoxiaÀÇ ¿µÇâ. ÃÖ½ÅÀÇÇÐ 14(2): 91-93, 1971.
È«À±Ç¥: °¡ÅäÀÇ ¿ä»ê¹è¼³¿¡ °üÇÑ ½ÇÇèÀû ¿¬±¸. ´ëÇѾฮÇÐȸÁö. 7: 67-74, 1971.
ÀÌ´öÈñ, ¹ÚöÈÆ, ÀÌ»óº¹: ÀλïÀÌ ÀûÇ÷±¸ ö¼·Ãë¿¡ ¹ÌÄ¡´Â ¿µÇâ. Áß¾ÓÀÇÇÐ 20(2): 167-170, 1971.
ÀÌ»óº¹, ÀÌ´öÈñ, ÀÌÈï¹ý: ÀλïÀÌ Á¶Ç÷±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ. ÃÖ½ÅÀÇÇÐ 14(3): 91-95, 1971.
ÇϺ´±¹, ±èÀ¯¼º, ±è¿øÀÚ, ¹ÚöÈÆ: ¿ì¸®³ª¶ó ¹éºÎÀÚÀÇ ÀûÃâ Á¶°³ ½ÉÀå¿îµ¿¿¡ ´ëÇÑ ÀÛ¿ë. ´ëÇѾฮÇÐÀâÁö 8(1): 15-25,
1972.
À¯¸í¿, ¹ÚÇü°æ, ÀÌÁ¤ÀÍ: ¸¶¿ì½º Carbonic anhydrase È°¼º¿¡ ¹ÌÄ¡´Â Xanthine À¯µµÃ¼ÀÇ ¿µÇâ. ´ëÇѾฮÇÐÀâÁö
8(1): 59-62, 1972.
ÀÌ´öÈñ, ±è±âÁø, ¹ÚÇü°æ: BradykininÀÌ Guanethidine Àüóġ °¡ÅäÀÇ Ç÷¾Ð¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐÀâÁö 8(1):
63-65, 1972.
Á¶±Ôö: Ç׾Ϲ°Áú°ú ±× À¯ÇØÀÛ¿ë. ´ëÇÑÀÇÇÐÇùȸÁö 15(9): 23-28, 1972.
¹ÚÇü°æ: ¼öÀºÀÌ´¢Á¦ÀÇ »ýü³» ºÐÆ÷. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 22: 131-138, 1972.
ÀÌÁ¤ÀÍ: °¨³ª¹« ¼ººÐÀÇ °áÁ¤È ¹× ÈòÁãÇ÷¾Ð¿¡ ´ëÇÑ ÀÛ¿ë. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 22: 139-146, 1972.
ÀÌ´öÈñ, Á¶±Ôö: AcetazolamideÀÇ Carbonic AnhydraseÈ°¼º ¾ïÁ¦ÀÛ¿ë¿¡ ´ëÇÑ Xanthine À¯µµÃ¼ÀÇ ¿µÇâ.
°¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 23: 15-24, 1972.
±è±âÁø: žÆÀÇ ÀûÇ÷±¸ »ý¼º Á¶Àý±â´É. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 23: 49-57, 1972.
Á¶±Ôö: ¾à¹°»óÈ£ÀÛ¿ë. ´ëÇѾฮÇÐÀâÁö 8(2): 5-20, 1972.
¹ÚöÈÆ, ÇϺ´±¹, ¹é¿î»ó, ÇѽÃÁØ: ¿Á¼ö¼ö ¼ö¿°ÀÇ ¹° ÃßÃâ¹°ÀÌ Ç÷¾Ð¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐȸÁö 8(2): 1-6, 1972.
±è¿Á³à: ´ëȲ¼ººÐ°ú ±×¿Ü ¾à¹°µéÀÇ ÈòÁã À§±Ë¾ç ¹æ¾îÀÛ¿ë. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 23: 37-45, 1972.
ÀÌ´öÈñ, À嵿¿ø, ÀÌ»óº¹: P-dimethylaminobenzaldehyde ÀÇ Ç×Áø±ÕÀÛ¿ë. Áß¾ÓÀÇÇÐ 22: 27, 1972.
Á¶º´Çå, ÀÌ»óº¹, ÀÌ´öÈñ, ¹ÚöÈÆ: ÀλïÀÌ ½ÇÇèÀû °íÇ÷¾Ð¿¡ ¹ÌÄ¡´Â ¿µÇâ ¹× ±× ±âÀü¿¡ °üÇÑ ¿¬±¸. ´ëÇѾฮÇÐȸÀâÁö 8(1):
49-57, 1972.
±è¿øÀÚ, ¹é¿î»ó, ÇÏ¸í±¹, ±è±âÁø: ´ëȲÀÇ ¾ËÄÝ ÃßÃâ¹°ÀÌ Åä³¢ ÀûÃâÀå°ü¾Ö ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐȸÁö. 8(1): 77-87,
1972.
±è¿Á³à, ÀÌÁ¤ÀÍ, ¹ÚÀºÈ£: ´ëȲÀÇ ¾ËÄÝÃßÃâ¹°ÀÌ ÈòÁã Àå°ü ¹× À§¿îµ¿¿¡ ¹ÌÄ¡´Â ¿µÇâ. Áß¾ÓÀÇÇÐ 22(2): 153-157, 1972.
¹ÚÀºÈ£: AcetozolamideÀÇ ¾È¾Ð °ÇÏÀÛ¿ë¿¡ ´ëÇÑ XanthineÀ¯µµÃ¼ÀÇ ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 23: 175-183,
1972.
¹é¿î»ó: Corticosyteroids Á¡¾ÈÀÌ ¾È¾Ð ¹× Acetazolamide ÀÇ ¾È¾ÐÇÏ°ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкÎ
³í¹®Áý 24: 11-18, 1973.
À¯¸í¿: GlucocorteroidÀÇ ÀûÇ÷±¸ »ý¼º±â´É¿¡ ´ëÇÑ ÀÛ¿ë. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 24: 151-159, 1973.
ÇѽÃÁØ: ¿Á¼ö¼ö ¼ö¿° ¼ººÐÀÇ ¾à¸®Àû ÀÛ¿ë. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 25: 293-304, 1973.
ÀÌÁ¾È, Á¶¼±Èñ, ¼Ûº´¼÷, ¹é¿î»ó: Á¦Ãæ±¹È À¯Ãâ¹°ÀÇ Ç×Áø±ÕÀÛ¿ë. ´ëÇѾฮÇÐÀâÁö 9(1): 17-22, 1973.
±è¿øÀÚ, Á¶¼±Èñ, ¼Ûº´¼÷, ÇϺ´±¹: ¿Á¼ö¼ö ¼ö¿°ÀÇ ¹° ÃßÃâ¹°ÀÌ Åä³¢ ÀûÃâ Àڱÿ¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐÀâÁö 9(1): 1-9,
1973.
ÀÌÁ¾È, ±è¿øÀÚ, ¼Ûº´¼÷, Á¶¼±Èñ: ¹é¿©·Î±Ù°æ ÃßÃâ¹°ÀÇ Ç×Áø±ÕÀÛ¿ë. ´ëÇѾฮÇÐÀâÁö 9(2): 21-27, 1973.
¹ÚöÈÆ, ±èÁ¤ÀÏ: ¾çä¼ÛÈÀÇ ¾ËÄÚȦ ÃßÃâ¹°ÀÌ ÀûÃâ Á¶°³ ½ÉÀå ¿îµ¿¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐÀâÁö 9(2): 29-37, 1973.
±èÀ¯¼º, Á¶±Ôö: AcetazolamideÀÇ Carbonic AnhydraseÈ°¼º ¾ïÁ¦ÀÛ¿ë¿¡ ´ëÇÑ CorticosteroidsÀÇ
¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 24: 69-78, 1973.
ÇϺ´±¹, Á¶±Ôö: AcetazolamideÀÇ Carbonic AnhydraseÈ°¼º ¾ïÁ¦ÀÛ¿ë¿¡ ´ëÇÑ DOCA ¹× Fludrocortisone
ÀÇ ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 24: 237-247, 1973.
±è¿øÀÚ, Á¶±Ôö: AcetazolamideÀÇ Carbonic AnhydraseÈ°¼º ¾ïÁ¦ ÀÛ¿ë¿¡ ´ëÇÑ Progesterone ¹×
Estradiol ÀÇ ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 25: 115-125, 1973.
ÀÌÁ¾È, ¼Ûº´¼÷, Á¶¼±Èñ, ±èÁ¤ÀÏ: Å亹·É ¾ËÄÚ¿Ã ÃßÃâ¹°ÀÇ ÇÑÁø±ÕÀÛ¿ë. ´ëÇѾฮÇÐȸÁö 9(2): 39-45, 1973.
ÀÌÁ¾È, ±èÁ¤ÀÏ, ¼Û¹ÎÀÚ: Å亹·É ¾ËÄÚ¿Ã ÃßÃâ¹°ÀÌ Åä³¢ÀûÃâ ½ÊÀÌÀå°ü¿îµ¿¿¡ ¹ÌÄ¡´Â¿µÇâ. ´ëÇѾฮÇÐȸÁö 9(2), 47-53, 1973.
¾î¿µ¼±: ¾çÃø ´¢°ü °áÂû°ú ¾çÃø ½ÅÀûÃâÀÌ Erythropoietin È°¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 24: 371-384,
1973.
¹Ú°æ¼÷: Åä³¢ Àڱÿ¿¡ ¹ÌÄ¡´Â Ȳ·Ã¼ººÐÀÇ ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 24, 57-68, 1973.
Á¶º´Çå, ÀÌ»óº¹, ¹ÚöÈÆ: ¼±ÀÎÀå(Opuntia elata) ¿¡Åº¿Ã ÃßÃ⼺ºÐÀÇ ¾à¸®ÀÛ¿ë. ´ëÇѾฮÇÐȸÁö 10(2): 43-54,
1974.
¼Ûº´¼÷, Á¶±Ôö: AcetazolamideÀÇ Carbonic AnhydraseÈ°¼º ¾ïÁ¦ ÀÛ¿ë¿¡ ´ëÇÑ Hydrocortisone
°ú Aminophylline º´ÇÕÅõ¿©ÀÇ ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 26: 363-372, 1974.
ÃÖ¸íÇÐ: Estradiol ¹× ProgesteroneÀÌ Á¶Ç÷±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 26: 385-392,
1974.
Á¶±Ôö: Enzyme Therapy. ´ëÇÑ»ýÈÇÐÇùȸÁö 6(2): 59-62, 1974.99
Á¶±Ôö, ÀÌ»óº¹, ÀÌ´öÈñ, ÀÌÁ¾È: ºÎ½ÅÇÇÁú È£¸£¸óÀÌ Ç÷Àå Erythropoietin È°¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐȸÀâÁö 10(2):
55-62, 1974.
ÀÌÁ¾È, ÀÌ´öÈñ, Á¶±Ôö: HydrocortisoneÀÇ ½Åµ¿¸Æ ÁÖÀÔÀÌ acetazolamide ¹× aminophyllineÀÇ
ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐȸÁö 10(2): 63-74, 1974.
¼Û¹ÎÀÚ: ÅûçÀÇ ÀÌ´¢ÀÛ¿ë. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 27: 177-186, 1974.
¹ÚöÈÆ: ¼±ÀÎÀå ¾ËÄÚ¿Ã ÃßÃâ ¼ººÐÀÇ ¾à¸®ÀÛ¿ë. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 27: 667-673, 1974.
±èÁ¤ÀÏ: Åä³¢ Àڱÿ¿¡ ¹ÌÄ¡´Â »çöä¼ÛÈ ¼ººÐÀÇ ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 26: 123-134, 1974.
Á¶¼±Èñ, ±èÁ¤ÀÏ: ¸ÅÀÚ³ª¹«¼ººÐÀÌ ¸¶¿ì½º ¼ö¸é ¹× ü¿Â¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐȸÁö 10(1): 61-65, 1974.
±è¿Á³à: Ȳ·Ã¼ººÐÀÇ ÀûÃâÁ¶°³ ½ÉÀå¿îµ¿¿¡ ´ëÇÑ¿¬±¸. Áß¾ÓÀÇÇÐ 33(3): 303-307, 1974,.
À嵿¿ø, ÀÌ»óº¹, Á¶±Ôö: AcetazolamideÀÇ Carbonic Anhydrase È°¼º¾ïÁ¦ ÀÛ¿ë¿¡ ´ëÇÑ TestosteroneÀÇ
¿µÇâ. ´ëÇѾฮÇÐȸÀâÁö 11(2): 1-8, 1975.
<1976¡1980>
<±¹ ³»>
°ûÀμ÷, ÀÌ»óº¹, Á¶º´Çå, Á¶±Ôö: Ȳ·Ã¼ººÐÀÇ Ç÷¾ÐÇÏ°ÀÛ¿ë. ´ëÇѾฮÇÐȸÀâÁö 12(2): 61-64, 1976.
ÀÌÁ¾È, Á¶±Ôö: °¡ÅäÀÇ ½Åµ¿¸Æ¿¡ ÁÖÀÔÇÑ Norepinephrine, Epinephrine ¹× AcetylcholineÀÌ ½ÅÀå±â´É¿¡
¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 29: 55-67, 1976.
ÀÌÁ¾È, Á¶º´Çå: µî½ÉÃÊ°¡ Åä³¢ ½ÅÀå±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ. ÃÖ½ÅÀÇÇÐ 19(4): 435-443, 1976.
À嵿¿ø, ¹ÚöÈÆ, Á¶º´Çå, Á¶±Ôö: ¼öÁ¾»ý¾àÀÇ ÀÌ´¢È¿°ú °üÂû¼Ò°ß. Áß¾ÓÀÇÇÐ 30(2): 191-197, 1976.
Á¶±Ôö: ¼öÀºÀÌ´¢Á¦. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 30(1): 1-15, 1976.
ÀÌÁ¾Çå, ÀÌ»óº¹, Á¶º´Çå, Á¶±Ôö: AcetazolamideÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â HydrocortisoneÀÇ Áõ°ÀÛ¿ë. Áß¾ÓÀÇÇÐ
32(1): 11-16, 1976.
ÀÌ»óº¹, Á¶±Ôö: ClonidineÀÇ ÁßÃß¼º ±³°¨½Å°æ¾ïÁ¦ÀÛ¿ë¿¡ ´ëÇÑ dopamine Â÷´ÜÁ¦ÀÇ ¿µÇâ. ´ëÇÑÀÇÇÐÇùȸÁö 20(2):
1-7, 1977.
±è¿Á³à: Ȳ·Ã¼ººÐÀÇ ÀûÃâÁ¶°³ ½ÉÀå¿îµ¿¿¡ ´ëÇÑ¿¬±¸. Áß¾ÓÀÇÇÐ 33(3): 303-307, 1977.
ÀÌ»óº¹, ±è¿Á³à, Á¶º´Çå, Á¶±Ôö: Çѱ¹»ê »ý¾àÁ¦µéÀÇ Ç÷¾ÐÇÏ°ÀÛ¿ë¿¡ ´ëÇÑ ¿¬±¸: I. Ȳ·Ã, Åûç, ¿À°¡ÇÇ. ÃÖ½ÅÀÇÇÐ 21(4):
71-79, 1977.
ÀÌÁ¾Çå, Á¶±Ôö: AcetazolamideÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â HydrocortisoneÀÇ Áõ°ÀÛ¿ë ºÎÀ§. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý
31(1): 189-193, 1978.
°ûÀμ÷, Á¶±Ôö: HydrocortisoneÀÌ AcetazolamideÀÇ Carbonic Anhydrase È°¼º¾ïÁ¦ÀÛ¿ë¿¡ ¹ÌÄ¡´Â
¿µÇâ °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 31(1): 195-199, 1978.
±è¿Á³à, ÀÌ»óº¹: µÎÃæ ¸ÞŸ³îÃßÃâ¹°ÀÇ Ç÷¾ÐÇÏ° ÀÛ¿ë. ÃÖ½ÅÀÇÇÐ 21(3): 1-5, 1978.
Á¶±Ôö: Endogenous opioid peptides¿¡ ´ëÇÏ¿©. ÃÖ½ÅÀÇÇÐ 21(7). 20-23, 1978.
Á¶º´Çå, ±èÀÎÈ£, ÀÌ»óº¹, Á¶±Ôö, ÀÌÁ¾È: Çѱ¹»ê »ý¾àÁ¦µéÀÇ Ç÷¾Ð°ÇÏÀÛ¿ë¿¡ ´ëÇÑ ¿¬±¸ (II). ´ëÇѾฮÇÐȸÀâÁö 15(1):
45-56, 1979.
ÀÌ»óº¹, ¿°À±Èñ, ÀÌÁ¾È, ±è¿Á³à, Á¶±Ôö: ¹«¸¶Ãë Åä³¢ÀÇ Ãø³ú½Ç·Î Åõ¿©µÈ PropranololÀÇ Ç÷¾Ð°ÇÏ ÀÛ¿ë. Àΰ£°úÇÐ 3(4):
45-51, 1979.
ÀÌÁ¾È, ÀÌ»óº¹, Á¶º´Çå, Á¶±Ôö: ¥á-Tri-thio-acetaldehydeÀÇ ¾à¸®ÀÛ¿ë (1): Ç÷¾Ð°ÇÏÀÛ¿ë ¹× ÀÌ´¢ÀÛ¿ë.
Áß¾ÓÀÇÇÐ 36(1): 65-73, 1979.
ÀÌÁ¾È, ±èÀμø, ±è¿Á³à, Á¶º´Çå, Á¶±Ôö: Çѱ¹»ê »ý¾àÁ¦µéÀÇ Ç÷¾Ð°ÇÏÀÛ¿ë¿¡ ´ëÇÑ ¿¬±¸(¥²):¹Ú´Þ¼öÇÇÀÇ Ç÷¾å¿¡ ´ëÇÑÀÛ¿ë. Çѱ¹»ý¾àÇÐȸÁö
10(3): 125-135, 1979.
±èÀμø, Á¶±Ôö: Reserpine Àüóġ°¡ Furosemide ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 32(1):
27-36, 1979.
±èÀμø, ÀÌ»óº¹, Á¶±Ôö: Penicillin G ÁÖÀÔÀÌ Furosemide ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐȸÀâÁö 16(2):
9-14, 1980.
È«°üÈñ, Á¶±Ôö: Hydrocortisone Àüóġ°¡ Furosemide ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 33(3):
471-476, 1980.
±è¼ºÀÚ, Á¶±Ôö: ¾ËÄ«¸®¼º ´¢°¡ Furosemide ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 33(3): 477-481,
1980.
ÀÌÁ¾È, Á¶±Ôö: Åä³¢ ½ÅÀå¿¡¼ PAHÀÇ ÀÌ´¢ÀÛ¿ë°ú À¯±â»êÀÇ ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 33(4): 759-772, 1980.
±èÀμø, ¿°À±Èñ, ÀÌ»óº¹, Á¶º´Çå, Á¶±Ôö: ¼öÁ¾»ý¾àÁ¦°¡ ½Å±â´É ¹× ½ÅÀå Na+-K+-ATPase¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐȸÀâÁö
16(1): 51-56, 1980.
<1981¡1985>
<±¹ ³»>
Yeom YH, Lee JH, Kim IS, Kim ON, Cho KC: Effect of acetazolamide on the
diuretic action of furosemide in rabbits. Kor J Pharmacol 17(2): 63-67,
1981.
¿°À±Èñ, ¿ëÀçÀÍ, Á¶±Ôö: FurosemideÀÇ °¡Åä ½Å¼¼´¢°ü ¼ö¼Û¿¡ ´ëÇÑ CephalexinÀÇ ¿µÇâ. Àΰ£°úÇÐ 5(3): 49-55,
1981.
ÀÌ¿µÈñ, Á¶±Ôö: Prostaglandin E1ÀÌ ÈòÁã ½ÅÁ¶Á÷³» Carbonic Anhydrase È°¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ
ÀÇÇкΠ³í¹®Áý 34(3): 405-410, 1981.
±è±¤¼ö: FurosemideÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ´ëÇÑ Acetazolamide ¹× MersalylÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý
34(4): 655-668, 1981.
±èÀÎÈ£, ÀÌ»óº¹: Äݸ°¼º ¾à¹°ÀÇ ÁßÃßÅõ¿©°¡ ½ÉÇ÷°ü°è¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 34(4): 669-679, 1981.
±èÀμø, ¿°À±Èñ, ÀÌ»óº¹, Á¶º´Çå, Á¶±Ôö: ClonidineÀÌ °¡Åä ½Å±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ. Àΰ£°úÇÐ 5(4): 65-67,
1981.
ÀÌ»óº¹, ±èÀμø, ±è¿Á³à, Á¶±Ôö: ½ÉÇ÷°ü°èÀÇ ÁßÃßÁ¶Àý¿¡ ´ëÇÑ Prostaglandin F2¥áÀÇ ¿µÇâ. ´ëÇѾฮÇÐȸÀâÁö 18(1):
11-16, 1982.
Á¶±Ôö, ±èÀμø, ¾çÀçÇÏ, ¹Ú¿µ¼: ÈòÁã ½ÅÁ¶Á÷³» Cyclic Nucleotide ÇÔ·®¿¡ ¹ÌÄ¡´Â Hydrocortisone °ú
FurosemideÀÇ ¿µÇâ. Kor J Pharmacol 19(1): 93-99, 1983.
¹Ú¿µ¼: FurosemideÀÇ ÀÌ´¢ÀÛ¿ë°ú ½ÅÁ¶Á÷³» cyclic nucleotide ÇÔ·®¿¡ ¹ÌÄ¡´Â hydrocortisoneÀÇ
¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 36(2): 515-525, 1983.
À̿쿵, Á¶±Ôö: ÈòÁãÀÇ ½ÅÁ¶Á÷³» cyclic nucleotides¿¡ ¹ÌÄ¡´Â ÀÌ´¢Á¦ÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 36(1):
23-28, 1983.
ÀÌÃæÈÆ, Á¶±Ôö: ÈòÁã ½ÅÁ¶Á÷³» carbonic anhydrase¿¡ ¹ÌÄ¡´Â furosemide¿Í prostaglandin E1ÀÇ
¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 36(1): 29-35, 1983.
±èÀμø, ÀÌ»óº¹, Á¶±Ôö: Vanadium ÀÌ ½ÅÀå Na-K-ATPase ¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѾฮÇÐȸÀâÁö 19(1): 449-454,
1983.
ÀÌ»óº¹: ½ÉÇ÷°ü°èÀÇ ÁßÃßÁ¶Àý¿¡ ´ëÇÑ DopamineÀÇ ¿µÇâ. Áß¾ÓÀÇÇÐ 44(2): 153-157, 1983.
Á¤À±¸ð: FurosemideÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ´ëÇÑ ¼Ò¿°Á¦ÀÇ ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 36(2): 383-393, 1983.
¹Ú¿ì¹è: ¹«¸¶Ãë ÈòÁãÀÇ Ãø³ú½ÇÀÇ Åõ¿©ÇÑ Prostaglandin E2, F2aÀÇ ½ÉÇ÷°ü°è¿¡ ´ëÇÑ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý
36(2): 395-403, 1983
À̱ÇÇà, Á¶±Ôö: Vanadate°¡ Åä³¢ ½ÊÀÌÁöÀåÀÇ ¼öÃà·Â¿¡ ¹ÌÄ¡´Â È¿°ú. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 37(1): 7-12, 1984.
½ÅÀͱÕ, ÀÌ»óº¹: ½ÉÇ÷°ü°èÀÇ ÁßÃß¼º Á¶Àý±âÀü¿¡ ´ëÇÑ prostaglandin E2ÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 37(1):
13-18, 1984.
È«±âºÀ, ÀÌ»óº¹: ¹«¸¶Ãë Åä³¢¿¡¼ Ãø³ú½Ç¿¡ Åõ¿©µÈ muscarine¼º ¾à¹°ÀÌ ½ÉÇ÷°ü°è¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý
37(1): 19-25, 1984.
ÀÌ¿µÈñ: AspirinÀÌ FurosemideÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 37(2): 369-378,
1984.
¼¿µÁø, À̱ÇÇà, ±è¿Á³à, ÀÌ»óº¹, Á¶±Ôö: Åä³¢ÀÇ Ç÷Àå³» Aldosterone ³óµµ¿¡ ¹ÌÄ¡´Â Aspirine°ú FurosemideÀÇ
¿µÇâ. ´ëÇѾฮÇÐȸÁö 20(2): 1-6, 1984.
À̼®¿ë, ±è¿Á³à, ÀÌ»óº¹, Á¶±Ôö: ÈòÁãÀÇ Ãø³ú½Ç¿¡ Åõ¿©µÈ GABA À¯»ç¹°ÁúÀÇ ½ÉÇ÷°ü°è¿¡ ´ëÇÑ ¿µÇâ. Áß¾ÓÀÇÇÐ 47(1): 35-43,
1984.
ÀÌ»óº¹, ±è¿Á³à: Á¤»ó ¹× ÀÚ¿¬ ¹ß»ý¼º °íÇ÷¾Ð ÈØÁã¿¡¼ Ç÷¾ÐÁ¶Àý¿¡ ´ëÇÑ ÁßÃß Äݸ°¼º ´º·ÐÀÇ ¿ªÈ°. Áß¾ÓÀÇÇÐ 46(1): 1-6,
1984.
Á¶±Ôö: ºÎÁ¾°ú ÀÌ´¢Á¦. ´ëÇÑÀÇÇÐÇùȸÁö 28(12): 1179-1185, 1985.
À̼®¿ë, À̱ÇÇà, ±è¿Á³à, ÀÌ»óº¹, Á¶±Ôö: ÈòÁãÀÇ ½ÅÁ¶Á÷³» Cyclic Nucleotide ÇÔ·®¿¡ ´ëÇÑ Aspirin, Indomethacin
¹× Furosemide ÀÇ »óÈ£ÀÛ¿ë. ÃÖ½ÅÀÇÇÐ 38(6): 40-46, 1985.
À̸í¿ì, ÀÌ»óº¹: ÈòÁã Ãø³ú½Ç¿¡ Åõ¿©ÇÑ muscimolÀÇ ½ÉÇ÷°ü ÀÛ¿ë ¹× ÁßÃß¼º Äݸ°½Å°æÀü´Þ°úÀÇ °ü°è. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý
38(2): 501-511, 1985.
ÇÑÅ¿ø, ÀÌ»óº¹: Åä³¢ Ãø³ú½Ç¿¡ Åõ¿©ÇÑ Nicotine¼º ¾à¹°ÀÌ ½ÉÇ÷°ü°è¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 38(3):
677-684, 1985.
ÀÌ»óºÀ, ÀÌ»óº¹: Åä³¢¿¡¼ FurosemideÀÇ ¿°¼Ò¹è¼³ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¥ãAminobutyric AcidÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкÎ
³í¹®Áý 38(4): 873-881, 1985.
<1986¡1990>
<±¹ ³»>
À̱ÇÇà, È«°æÀÚ, ½ÅÀͱÕ, ±è¿Á³à, ÀÌ»óº¹, Á¶±Ôö: Åä³¢¿¡¼ ProcaineÀÇ Àü½ÅÅõ¿©°¡ ½Å±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ. ÃÖ½ÅÀÇÇÐ 29(6):
39-44, 1986.
À̱ÇÇà, Á¶±Ôö: Ä®½·ÀÌ ÀûÃâ °ü·ù Åä³¢ ½ÅÀå¿¡¼ FurosemideÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 39(4):
1109-1118, 1986.
±èÇмú: ÈòÁã ½ÅÁ¶Á÷³» Guanylate Cyclase¿¡ ´ëÇÑ FurosemideÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 39(2):
395-403, 1986.
ÀÌÃæÈÆ, Á¶±Ôö: Furosemide°¡ ÀûÃâ °ü·ù Åä³¢½ÅÀå ±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 39(2): 529-537,
1986.
Áøµ¿Âù, ±è¿Á³à: AspirinÀÌ BenzothiadiazideÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 39(3):
741-749, 1986.
À̿쿵, Á¶±Ôö: Hydrochlorothiazide°¡ ½ÅÀå±â´É ¹× ½ÅÁ¶Á÷³» Cyclic Nucleotides ÇÔ·®¿¡ ¹ÌÄ¡´Â
¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 39(4): 1099-1108, 1986.
½ÅÀͱÕ, ÀÌ»óº¹: ÈòÁã º¹¿ÜÃø ¿¬¼öÀÇ ½Â¾ÐºÎÀ§¿¡¼ ½ÉÇ÷°ü Á¶Àý¿¡ ´ëÇÑ GABA¼º ±âÀü. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 39(4): 1119-1128,
1986.
Lee SY, Koh TL, Lee WY, Lee SB, Cho KC: Effects of hydrochlorothiazide
on the renal cyclic nucleotides level. Kor J Pharmacol 22(2): 128-134,
1986.
Lee KH, Chun EE, Hong KJ, Cho KC: Role of calcium in function of isolated
perfused rabbit kidney. Kor J Pharmacol 22(2): 135-143, 1986.
Kim SY, Koh TL, Lee SB: Cholinergic mechanisms on cardiovascular regulation
in the ventrolateral medulla of the rat. Kor J Pharmacol 23(2): 77-85,
1987.
À̱ÇÇà, À̼®¿ë, ±è¿Á³à, ÀÌ»óº¹, Á¶±Ôö: Ä®½· ±æÇ×Á¦°¡ ÀûÃâ °ü·ù Åä³¢½ÅÀå ±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ. ÃÖ½ÅÀÇÇÐ 30(5): 63-67,
1987.
ÀüÀºÀÇ, Á¶±Ôö: QuinidineÀÌ ÀûÃâ°ü·ù Åä³¢½ÅÀå¿¡¼ FurosemideÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý
40(1): 41-49, 1987.
ÀÓ¿ÏÈñ, Á¶±Ôö: DiltiazemÀÌ Åä³¢½ÅÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 40(1): 51-59, 1987.
±èÁøÇÑ, Á¶±Ôö: ÀûÃâ°ü·á Åä³¢½ÅÀå¿¡¼ ¾Æ½ºÇǸ°ÀÌ Ä®½·ÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 40(3): 651-
658, 1987.
À±¿©È«, ÀÌ»óº¹: ÈòÁã º¹¿ÜÃø ¿¬¼öÀÇ ½Â¾ÐºÎÀ§¿¡¼ ½ÉÇ÷°ü Á¶Àý¿¡ ´ëÇÑ Muscarine¼º ±âÀü. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 41(1):
43-52, 1988.
ÀÌ¿ë¿ì, ÀÌ»óº¹: ÈòÁã °í¼ÓÇÙ¿¡ ¹Ì¼¼ÁÖ»çÇÑ Nicotine¼º ¾à¹°ÀÇ ½ÉÇ÷°ü ÀÛ¿ë. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 41(1): 53-60,
1988.
°íÅø³, ÀÌ»óº¹: ÈòÁã °í¼ÓÇÙ¿¡¼ ½ÉÇ÷°üÁ¶Àý¿¡ ´ëÇÑ Choline¼º ±âÀü. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 40(2): 501-511,
1988.
ÀÓ¿ë°É: ÀûÃâ°ü·ù Åä³¢½ÅÀå¿¡¼ Ä®½·ÀÌ AmilorideÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 41(2): 711-721,
1988.
À̱ÇÇà, ¼º±â¿í, È«°æÀÚ, ÀÌ»óº¹, Á¶±Ôö: ÀûÃâ°ü·ù Åä³¢½ÅÀå±â´É¿¡ ´ëÇÑ Å°´ÑÀÇ ¿µÇâ. ´ëÇѽÅÀåÇÐȸ ÀâÁö 7(1): 18-25,
1988.
À̱ÇÇà, Á¶±Ôö: Á¤»ó ¹× ÀÌ´¢¼º ÈòÁã ½ÅÀå Á¶Á÷¿¡¼ »ïÅõ¼º À¯±â¹°ÁúÀÇ ³óµµ. ´ëÇѽÅÀåÇÐȸ 8(3): 407-414, 1989.
ÀÓºÀ¿, Á¶±Ôö: ÀûÃâ°ü·ù Åä³¢½ÅÀå¿¡¼ Ä®½·ÀÌ BradykininÀÇ ÀÌ´¢ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐÀÇÇкΠ³í¹®Áý 42: 41-49,
1989.
Ȳ±âÇö, Á¶±Ôö: Á¤»ó ¹× ÀÌ´¢¼º Åä³¢½ÅÀå¿¡¼ ¾Æ¹Ì³ë»êÀÇ ³óµµ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 42(4): 901-909, 1989.
¹Ú¼öÇå, ±è¿Á³à: ÈòÁ㠽ż¼´¢°üÀÇ »ê¼Ò¼Òºñ·®¿¡ ´ëÇÑ BradykininÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 43(1): 145-152,
1989.
¼º±â¿í, ±è¼ºÀ±, ÀÌ»óº¹, Á¶±Ôö: ÈòÁã °í¼ÓÇÙ¿¡¼ ½ÉÇ÷°ü Á¶Àý¿¡ ´ëÇÑ Serotonin¼º ±âÀü. ´ëÇÑÀÇÇÐÇùȸÁö 32(7):
743-750, 1989.
±è´ë¿ì, ÀÌ»óº¹: ¸¶ÃëÇÑ Á¤»óÇ÷¾Ð ¹× ÀÚ¿¬¹ß»ý¼º °íÇ÷¾Ð ÈòÁãÀÇ °í¼ÓÇÙ¿¡ Á¸ÀçÇÏ´Â Choline¼º ¼ö¿ëü¿¡ ÀÇÇÑ ½ÉÇ÷°ü±â´ÉÀÇ Á¶ÀýÀÛ¿ë.
°¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 42(1): 527-538, 1989.
Lee SY, Ro KS, Kim ON, Lee SB, Cho KC: Effects of loop diuretics on guanylate
cyclase in rat medullary thick ascending limb of Henle's loop. Kor J Pharmacol
25(1): 59-66. 1989.
¼º±â¿í, ÀÌ»óº¹: Á¤»óÇ÷¾Ð¹× ÀÚ¿¬ ¹ß»ý¼º °íÇ÷¾Ð ÈòÁãÀÇ º¹¿ÜÃø ¿¬¼ö¿¡ Á¸ÀçÇÏ´Â choline¼º ¼ö¿ëü¿¡ ÀÇÇÑ ½ÉÇ÷°ü Á¶Àý±â´É.
°¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 43(1): 35-45, 1990.
Áøµ¿Âù, ±è¿Á³à: BradykininÀÌ ¹è¾çµÈ ½ÅÇÇÁú ¼¼´¢°ü ¼¼Æ÷³» Ä®½·³óµµ¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 43(4):
1111-1118, 1990.
¹Ú¼öÇå, ±è¿Á³à: ÈòÁ㠽ż¼´¢°üÀÇ »ê¼Ò ¼Òºñ·®¿¡ ´ëÇÑ BradykininÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 43(2): 47-53,
1990.
¼ÛÀΰü: ÈòÁã ½ÅÀåÇÇÁú ¼¼´¢°üÀÇ »ê¼Ò¼Òºñ·®¿¡ ´ëÇÑ BradykininÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 43(2): 669-677,
1990.
Lee SY, Cho KC: Effect of bradykinin on oxygen consumption in the distal
tubule and cortical collecting tubule of rat. Kor J Pharmacol 26(2): 161-166,
1990.
<±¹ ¿Ü>
Lee SB, Sung KW, Kim SY, Cho KC: Cholinergic mechanisms on cardiovascular
regulation in the nucleus tractus solitarius: funtional relationship between
cholinergic neuron & L-glutamate. Eur J Pharmacol 183(5): 1927, 1990.
<1991¡1995>
<±¹ ³»>
±èº¸¿¬, ÀÌ»óº¹: ÀÔ¿øÁßÀÎ Á¤½ÅÁõ ȯÀÚ¿¡¼ ¾à¹° ºñ¼øÀÀÀÇ °ü·Ã¿äÀÎ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 44(1): 45-55, 1991.
±è¼ºÀ±, Á¶¿µÁø, ¼º±â¿í, ±èÁ¤È¸, ±è¿Á³à, ÀÌ»óº¹: °í¼Ó¾×ü Å©·Î¸¶Åä±×¶óÇǸ¦ ÀÌ¿ëÇÑ Ciprofloxacin µÎ Á¦Á¦ÀÇ »ý¹°ÇÐÀû
µ¿µî¼ºÀÇ ½ÃÇè. °¨¿° 23(4): 271-278, 1991
±è±Ô¾ð, ±è¿Á³à: ÈØÁã ½ÅÀå³»¼öÁúÁýÇÕ°ü »óÇǼ¼Æ÷ÀÇ »ê¼Ò¼Òºñ·®¿¡ ´ëÇÑ BradykininÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 44(2):
379-389, 1991.
³ë°æ½Ä, ÀÌ»óº¹: ÈòÁã ½ÅÀå ±ÙÀ§¼¼´¢°üÀÇ Na-K-ATPaseÈ°¼º°ú »ê¼Ò ¼Òºñ·®¿¡ ´ëÇÑ ClonidineÀÇ ¿µÇâ. °¡Å縯´ëÇÐ
ÀÇÇкΠ³í¹®Áý 44(4): 1001-1010, 1991.
¹ÚÀοø, ÀÌ»óº¹: ÈØÁã ¸Á¸·¿¡¼ GABA“G Dopamine¼º ½Å°æ¿øÀÇ ºÐÆ÷¿Í ÀÌµé ¼¼Æ÷¿¡¼ÀÇ GABA¹× DopamineÀÇ °øÁ¸.
°¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 45(1): 43-50, 1992.
Sung KW, Kim SY, Cho YJ, Lee KH, Lee SB: In vivo measurement of extracellular
monoamines and their meta- bolites in the rat posterior hypothalamus using
microdialysis technique. Kor J Pharmacol 28(1): 1-8, 1992.
¼º¸¿ø: ÈòÁ㠽ſø ºÐÀý¿¡¼ ATP ¾ç¿¡ ´ëÇÑ ¾Æ¹Ì³ë±Û¶óÀ̵å Ç×»ýÁ¦ÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 45(2): 1-11,
1992..
ÃÖµ¿È£, ÀÌ»óº¹: ÈòÁã½ÅÀå¿¡¼ Cisplatin¿¡ ÀÇÇÑ ÁöÁú°ú»êÈ¿¡ ´ëÇÑ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý, 1992.
À̼®¿ë, ÀÌ»óº¹: ÈòÁã³» ¼öÁúÁýÇÕ°ü ¼¼Æ÷ÀÇ ´Éµ¿Àû Sodium¿î¹Ý¿¡ ´ëÇÑ Bradykinin°ú IndomethacinÀÇ ¿µÇâ.
ÃÖ½ÅÀÇÇÐ 35, 54-60, 1992.
À̼®¿ë, Á¶±Ôö: ÈòÁã³» ¼öÁúÁýÇÕ°ü ¼¼Æ÷¿¡¼ cGMP»ý¼º¿¡ ´ëÇÑ ANP¿Í AmilorideÀÇ »óÈ£ÀÛ¿ë. ÃÖ½ÅÀÇÇÐ 35, 11-16,
1992.
±è¼ºÀ±, ÀÌ»óº¹: Á¤»óÇ÷¾Ð ¹× ÀÚ¿¬¹ß»ý¼º °íÇ÷¾Ð ÈòÁã¿¡¼ Ç÷¾Ð°ú Ç÷Àå Ä«Å×ÄݾƹΠ³óµµ¿¡ ´ëÇÑ Äݸ°¿¡½ºÅͶóÁ¦ ¾ïÁ¦¾àÀÇ ÁßÃßÀÛ¿ë.
°¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý. 46(4): 1265-1276, 1993.
±èÀμø, À̼®¿ë, ±èÁ¤È¸, Á¶¿µÁø, ÀÌ»óº¹: Ç÷°ü»ý¼º ¹× °ü»ó±¸Á¶ Çü¼º¿¡ ¹ÌÄ¡´Â È÷½ºÅ¸¹ÎÀÇ ¿µÇâ. ´ëÇѾÏÇÐȸÁö 25, 607-615,
1993
Kim IS, Lee SB, Cho KC: Phosphorylation of ribosomal protein S6 and its
regulation during differentiation of human leukemic cells. J Kor Med Sci
8: 413-419, 1993.
ÃÖµ¿È£, ÀÌ»óº¹: ÈòÁã ½ÅÀå¿¡¼ ÁöÁú°ú »êÈ¿¡ ´ëÇÑ CisplatinÀÇ ¿µÇâ, °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý. 46(1): 21-29,
1993.
Á¶¿µÁø, Á¶±Ôö: Effects of cisplatin on free radical scavenging enzymes and
inhibitors of cisplatin-induced nephroxicty by free radical scavengers.
°¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 46(3): 753-762, 1993.
ÀÓºÀ¿, ÀÌ»óº¹: Cisplatin Åõ¿©°¡ ÈòÁã ½ÅÀåÀÇ È°¼º»ê¼Ò Á¦°ÅÈ¿¼Ò È°¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 46(4):
1255-1263, 1993.
±è¼ºÀ±, ¼º±â¿í, ±èÁ¤Áø, Á¶¿µÁø, ±è¿Á³à, ÀÌ»óº¹: °æ±¸Åõ¿©ÇÑ ofloxacine Á¤Á¦ÀÇ »ýü ÀÌ¿ëÀ²ÀÇ ºñ±³. ÀÓ»ó¾à¸®ÇÐȸÁö.
2(1): 21-29, 1994.
¹ÚÀοø: ÈòÁã ¸Á¸·¿¡¼ Substance P¼º ½Å°æ¿øÀÇ ÀÎÁ¢±â±¸¿¡ ´ëÇÑ ¸é¿ª¼¼Æ÷ÈÇÐÀû ¿¬±¸. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 47(4):
1417-1430, 1994.
°íÇöö: ÁßÃß Ç÷¾Ð Á¶Àý¿¡ ÀÖ¾î¼ Ã´¼ö Nitric OxideÀÇ ¿ªÇÒ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 47(4): 1431-1442,
1994.
¿À¼¼±â, ÀÌ»óº¹: ÈòÁã ³»¼öÁú ÁýÇÕ°ü ¼¼Æ÷¿¡¼ Atrial Natriuretic PeptideÀÇ ¼ö¿ëü °áÇÕ°ú ÀüÇØÁú ¿î¹Ý ¾ïÁ¦ÀÛ¿ë¿¡
´ëÇÑ AmilorideÀÇ ¿µÇâ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý 47(1): 97-105, 1994.
¾çµ¿¿ø, ÀÌ»óº¹: N-Methyl-D-Asparate ¼ö¿ëü ±æÇ×ü MK-801ÀÇ ÈòÁã ½ÉÇ÷°ü°è¿¡ ´ëÇÑ ÀÛ¿ë. °¡Å縯´ëÇÐ ÀÇÇкÎ
³í¹®Áý 48(1): 21-32, 1995.
Kim SH, Cho YJ, Bae YJ, Lee KH, Lee SB: Effect of biphenyl bicarboxylate
on chemical-induced hepatotoxicity. Kor J Toxicol 11(2): 181-185, 1995.
ÃÖµ¿È£, ÀÌ»óº¹: L6±ÙÀ°¼¼Æ÷ÀÇ ºÐȽà phospholipase C µ¿À§È¿¼ÒÀÇ ºÐÆ÷ÇüÅÂ. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý. 48(4):
965-977, 1995.
¼º±â¿í¿Ü 9ÀÎ: Á¤»ó¼ºÀο¡ °æ±¸Åõ¿©ÇÑ Levofloxacin µÎÁ¤Á¦ÀÇ »ýü ÀÌ¿ëÀ²ÀÇ ºñ±³. ÀÓ»ó¾à¸®ÇÐȸÁö 3(2): 169-176,
1995.
±è°æ¼ö: ÈòÁã Ç÷¾× ¹× ³ú Á¶Á÷º° haloperidolÀÇ ºÐÆ÷¿¡ ´ëÇÑ ¾àµ¿ÇÐÀû »ó°ü¼º. °¡Å縯´ëÇÐ ÀÇÇкΠ³í¹®Áý. 49(2):
1-11, 1995.
<±¹ ¿Ü>
Lee SB, Kim SY, Sung KW: Cardiovascular regulation by cholinergic mechanisms
in rostral ventrolateral medulla of spontaneously hypertensive rats. Eur
J Pharmacol 205: 117-123, 1991.
Beits JG, Kim IS, Calabresi P, Frackeltan AR Jr: Human microvascular endothelial
cells express receptors for platelet-derived growth facter. Proc Natl
Acad Sci 88: 2021-2025, 1991.
Endou H, Jung KH, Lee KH: Role of ammonium ion in adenine triphosphate
consumption of the rat medullary thick ascending limb. Contribution to
Nephrology 92: 149-159, 1991.
Lee KH, Lee SB, Cho KC: Levels of organic osmolytes in normal and diuretic
rat kidney. Contributions to Nephrology 95: 279-283, 1991.
Kim SY, Sung KW, Kim YJ, Lee SY, Lee SB: Cardiovascular effects of various
cholinergic agents in nucleus tractus solitarius: Role of muscarinic and
nicotinic receptors. Asia Pacific J Pharmacol 7: 183-190, 1992.
Beitz JB, Kim I-S, Calabresi P, Frackelton AR Jr: Receptors for platelet-derived
growth factor on microvascular endothelial cells. In Angiogenesis: Key
Principles Science Technology-Medicine. ed. by Steiner R, Weisz PB, Langer
R. pp 85-90. Birkh user Verlag, Basel, 1993.
Diefer-Day JS, El-Sayed AMA, Forray C, Lee NH, Kim ON, El-Fakahany EE:
Effects of tacrine on brain muscarinic-receptor-mediated second-messenger
signals. Pharmacol 47: 98-110, 1993.
Jhon D-Y, Lee H-H, Park D, Lee C-W, Lee K-H, Yoo OJ, Rhee SG: Cloning,
sequencing, purification, and Gq-dependent activation of phospholipase
C-¥â3. J Biol Chem 268(9): 6654-6661, 1993.
Park D, Jhon D-Y, Lee C-W, Lee K-H, Rhee SG: Activation of phospholipase
C isozymes by G protein ¥â¥ã subunits. J Biol Chem 268(7): 4573-4576, 1993.
Lee CW, Lee KH, Lee SB, Park D, Rhee SG: Regulation of phospholipase C-¥â4
by ribonucleotides and the ¥á subunit of Gq. J. Biol. Chem. 269: 25335-25338,
1993..
Lee CW, Park DJ, Lee KH, Kim CK, Rhee SG: Purification molecular cloning,
sequencing of phospholipase C-¥â4. J Biol Chem 268, 21318-21327, 1993.
Lee CW, Lee KH, Rhee SG: Purification of phospholipase C-¥â4 and phospholipase
C-¥ä2 from bovine retinas. Methods in Neurosciences 18; 64-71, 1993.
Lee CW, Lee KH, Kim CK, Rhee SG: Characterization of PLC isozymes in bovine
retina: Purification of phospholipase C-¥â4. Methods in Enzymology 238;
227-237, 1994.
Lee KH, Cho YJ, Lee SB, Cho KC, Cha SH, Endou H: Evidence suggesting a
role for phospholipase C isozyme, PLC-¥ä1 in corticomedullary osmotic gradients
in rat kidneys. Biochem Mol Biol Internat 37: 25-32, 1995.
Lee SY, Kim ON, El-Fakahany EE: Inhibition of neuronal nitric oxide synthase
by antidepressants. Pharma Comm 7: 1-9, 1995.
Zhu SZ, Lee SY, Wang SZ, El-Fakahany EE: Investigation of the role of
an amino acid triplet repeat in differentiation drug-receptor interaction
at m1 and m2 muscarinic receptors. Pharmacology. 51: 298-307, 1995
<1996¡>
<±¹ ³»>
Lee SY, Lee SB: Effects of site-mutagenesis of an amino acid triplet repeat
at M1 and M2 muscarinic receptors on receptor function. Kor J Pharmacol
32:311-321, 1996
Lee SY, Sung KW, Kim ON, Lee SG: Enahnced coupling of M1 muscarinic receptors
to activation of phospholipase C upon mutation of a transposed amino acied
triplet repeat. Kor J Physiol Pharmacol 1: 19-25, 1997.
<±¹ ¿Ü>
Lee SB, Koh HC, Kim ON, Sung KW, Kim SY: Intrathecal administration of
sodium nitroprusside, a nitric oxide donor, increase blood pressure in
anesthetized rats. Neuroscience Letters 203: 53-56, 1996.
Wang SZ, Lee SY, Zhu SZ, El-Fakahany EE: Dofferential coupling of m1,
m3, and m5 muscarinic receptors to activation of neuronal nitric oxide
synthase. Pharmacol 53: 271-280, 1996.
Lee SY, Zhu SZ, El-Fakahany EE: Role of two highly conserved tyrosine
residues in the m1 muscarinic receptor second transmembrane domain in
ligand binding and receptor function. Receptors Signal Transduct (formerly
Receptor) 6: 43-52, 1996.
|